Moreover, TPM1 has been shown to be notably reduced in pancreatic cancer patients and drug-resistant pancreatic cancer cell lines, and a low TPM1 level was correlated with worse survival [14]. The gene discussed is TPM1; the disease is pancreatic neoplasm.